Rather & Kittrell’s Encompass Health EHC Stock Holding History

Rather & Kittrell’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-947	Closed	-$49K	–	127
2021 Q4	$49K	Buy	+947	New	+$48.9K	0.04%	127

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rather & Kittrell's EHC Position: Q1 2022 in Review

Rather & Kittrell sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 947 shares — an estimated $49K sold.

Rather & Kittrell first reported a position in EHC in Q4 2021 and held it in 1 quarter. The position peaked at $49K in Q4 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

Rather & Kittrell reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
Rather & Kittrell sold 947 Encompass Health shares in Q1 2022, an estimated $49K.
Rather & Kittrell first reported a position in Encompass Health in Q4 2021 and held it in 1 quarter.
Rather & Kittrell's Encompass Health position peaked at $49K in Q4 2021.
406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Rather & Kittrell's 13F filing for Q1 2022, filed 10 May 2022.